Home/Filings/4/0001345281-23-000004
4//SEC Filing

Masi Dina 4

Accession 0001345281-23-000004

CIK 0001016504other

Filed

Sep 20, 8:00 PM ET

Accepted

Sep 21, 10:51 AM ET

Size

7.5 KB

Accession

0001345281-23-000004

Insider Transaction Report

Form 4
Period: 2023-09-20
Masi Dina
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-09-20$0.09/sh+50,000$4,500147,200 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-09-20$0.09/sh50,000$4,500576,667 total
    Exercise: $0.09From: 2015-06-02Exp: 2025-06-02Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
  • [F2]50,000 stock options disposed of upon exercise of the portion of a stock option grant dated June 2, 2015. 200,000 stock options for the right to purchase common stock at $0.09 remain available to exercise.

Issuer

INTEGRATED BIOPHARMA INC

CIK 0001016504

Entity typeother

Related Parties

1
  • filerCIK 0001345281

Filing Metadata

Form type
4
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 10:51 AM ET
Size
7.5 KB